MCM7 amplification and overexpression are associated with prostate cancer progression.
about
Epidermal growth factor receptor potentiates MCM7-mediated DNA replication through tyrosine phosphorylation of Lyn kinase in human cancersmiR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinomaThe Mcm2-7 replicative helicase: a promising chemotherapeutic targetRe-replication of a centromere induces chromosomal instability and aneuploidyHigh fidelity copy number analysis of formalin-fixed and paraffin-embedded tissues using Affymetrix Cytoscan HD chip.Increased nucleotide polymorphic changes in the 5'-untranslated region of delta-catenin (CTNND2) gene in prostate cancerCell cycle arrest by transforming growth factor beta1 near G1/S is mediated by acute abrogation of prereplication complex activation involving an Rb-MCM interaction.Zbtb7a suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence bypass and tumor invasion.MicroRNA-218 is deleted and downregulated in lung squamous cell carcinoma.Inhibition of prostate cancer growth and metastasis using small interference RNA specific for minichromosome complex maintenance component 7.Pre-RC Protein MCM7 depletion promotes mitotic exit by Inhibiting CDK1 activity.Metallothionein 1 h tumour suppressor activity in prostate cancer is mediated by euchromatin methyltransferase 1Identification of the miR-106b~25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation.Dysregulation of the homeobox transcription factor gene HOXB13: role in prostate cancer.Quantification of miRNA-mRNA interactionsPlasma microRNA profiles: identification of miR-25 as a novel diagnostic and monitoring biomarker in oesophageal squamous cell carcinoma.TSA suppresses miR-106b-93-25 cluster expression through downregulation of MYC and inhibits proliferation and induces apoptosis in human EMC.MCM Paradox: Abundance of Eukaryotic Replicative Helicases and Genomic Integrity.Microfluidic-based multiplex qRT-PCR identifies diagnostic and prognostic microRNA signatures in the sera of prostate cancer patients.Single-stranded annealing induced by re-initiation of replication origins provides a novel and efficient mechanism for generating copy number expansion via non-allelic homologous recombination.The anti-proliferative effects of enterolactone in prostate cancer cells: evidence for the role of DNA licencing genes, mi-R106b cluster expression, and PTEN dosage.Minichromosome maintenance proteins interact with checkpoint and recombination proteins to promote s-phase genome stability.Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer.The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and BimOncogenic activity of MCM7 transforming cluster.Interaction of integrin-linked kinase and miniature chromosome maintenance 7-mediating integrin {alpha}7 induced cell growth suppression.Minichromosome Maintenance Protein 7 is a potential therapeutic target in human cancer and a novel prognostic marker of non-small cell lung cancerThe DNA replication licensing factor miniature chromosome maintenance 7 is essential for RNA splicing of epidermal growth factor receptor, c-Met, and platelet-derived growth factor receptorNovel fusion transcripts associate with progressive prostate cancer.Genomic Copy Number Variations in the Genomes of Leukocytes Predict Prostate Cancer Clinical Outcomes.Oncogenic Activity of miR-650 in Prostate Cancer Is Mediated by Suppression of CSR1 Expression.miR-93/106b and their host gene, MCM7, are differentially expressed in leiomyomas and functionally target F3 and IL-8.Genome abnormalities precede prostate cancer and predict clinical relapseProton irradiation impacts age-driven modulations of cancer progression influenced by immune system transcriptome modifications from splenic tissueCandidate genes contributing to the aggressive phenotype of mantle cell lymphoma.MicroRNA-106b-25 cluster expression is associated with early disease recurrence and targets caspase-7 and focal adhesion in human prostate cancer.Mitogenic growth signalling, DNA replication licensing, and survival are linked in prostate cancerInteraction of MCM7 and RACK1 for activation of MCM7 and cell growth.Green tea catechins suppress the DNA synthesis marker MCM7 in the TRAMP model of prostate cancer.Phosphorylation of minichromosome maintenance protein 7 (MCM7) by cyclin/cyclin-dependent kinase affects its function in cell cycle regulation
P2860
Q24294953-79BC4EE9-CA51-4639-A4E1-248AEBB7D653Q24658453-D91D6286-A366-48EA-B552-B6999D9B9D2AQ26861045-F2125EC5-AEB6-4303-9D08-0C320F1F27B0Q27311421-400CFA51-CC6A-45B7-A0C8-60AAFDD640C1Q31155844-42A39325-E7B6-4390-838F-580DDB9ECA52Q33382065-8478CBBE-1516-43D2-BC1B-B50124F61A28Q33614054-B3CF9297-B793-45E3-B0EF-FE4E013C8D48Q33677421-E4D8FC57-F98F-4C99-94FE-FA6FBFE50F0AQ33691330-BB66B42F-1DC3-4848-B0CA-861967FC5F5CQ33697912-ADF4A595-B85B-4751-A203-42793D40964FQ33767142-F118A9E2-B288-4D36-90D6-6589B47F5BE2Q33841451-03574050-7D31-4F8E-9D5D-2B58AB05CE15Q34109986-3F3F5440-0CC4-46C2-918E-4CA25992E4EBQ34147903-42832F47-44D7-4317-BA19-13C73DA4B6F2Q34163271-8D4BDDCC-77DD-4409-8E9F-8D094C17C973Q34354560-9C4DF1FC-1F60-45FC-9094-DFF6E3F97363Q34428174-44411664-236E-4DF3-928A-D097AAB8E8E9Q34441575-9E0B7267-8109-4F0D-A4EC-14541A342828Q34496664-F0B56D22-5776-4E8D-B5BA-82FA9CC4AAC4Q34539939-D3C0198C-803E-43BD-BF87-680C40120A80Q34577999-67F5A9ED-4EC5-4BEC-9128-976F724E6879Q34733887-83DEF7F8-EAA0-4939-A58D-694CCA2AC13AQ34803786-9B58F85F-EBD5-4071-B388-7B1B49F535EAQ34979616-318D2710-C820-4C03-B251-939709F82456Q34983842-717F6016-48E3-492E-AA41-57BA9C0A1CDAQ34990955-3334EEDB-4070-4226-A2D4-FD21E7A2A1CBQ35074445-274F82C7-6790-49C7-9AD7-2560DB42D508Q35121228-785148B1-7D96-4BBA-8438-CCCC063E5620Q35265643-ABF0ED8B-9E76-40EA-8C9A-8E9B52C64131Q35752335-40F676ED-5D27-40D1-8A4E-06E2BA5E1AF0Q35792806-16EB46EB-89C9-4902-A460-F37B1024248FQ35970092-C75CD414-9E4A-4E79-B9E6-8CD3143B3751Q36065143-E0A65A9B-DD37-413B-ACAE-72315DEC12DAQ36078666-3ABC35E0-2FE0-4A62-86B3-0D70D7F48676Q36315020-41922063-1F35-4094-8ABF-84A3F81CB478Q36488217-C24D0EDC-B790-4139-A5C3-0F8AFBBD2FDAQ36610377-BDAE8180-09B7-4CC0-ABB6-268374A8D134Q36651914-40679570-419D-49B9-B0B9-9477385257FBQ36692363-AC5033DF-CC31-4574-885C-AD7862A8D5F6Q37000584-8D4DFF82-0E9B-45EB-BFF3-D7DB52541EEA
P2860
MCM7 amplification and overexpression are associated with prostate cancer progression.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
MCM7 amplification and overexpression are associated with prostate cancer progression.
@en
type
label
MCM7 amplification and overexpression are associated with prostate cancer progression.
@en
prefLabel
MCM7 amplification and overexpression are associated with prostate cancer progression.
@en
P2093
P2860
P356
P1433
P1476
MCM7 amplification and overexpression are associated with prostate cancer progression.
@en
P2093
Michalopoulos G
P2860
P2888
P304
P356
10.1038/SJ.ONC.1209134
P407
P577
2006-02-01T00:00:00Z
P5875
P6179
1037475628